E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/1/2016 in the Prospect News Preferred Stock Daily.

Bank preferreds mostly up after stress test; Gabelli, National General tick higher

By Christine Van Dusen

Atlanta, July 1 – Trading of preferreds from U.S. banks was quiet on Friday, ahead of the July 4 holiday in the United States, with some upward movement for banks in the wake of the most recent round of stress tests.

Wells Fargo & Co.’s 5.5% series X class A noncumulative preferreds (NYSE: WFCPX) traded Friday morning up 14 cents to $25.92. The notes finished at $26.02.

Bank of America Corp.’s 6% series EE noncumulative preferreds (NYSE: BACPA) moved up 14 cents to $26.18 on Friday morning. The notes closed at $26.42.

And JPMorgan Chase & Co.’s 6.15% series BB noncumulative preferreds (NYSE: JPMPH) rose 8 cents to $26.83 on Friday morning. At the close the stock was seen at $26.80.

Last week, the Fed said that all of the 33 banks that were tested passed the stress review. The first round looks at a firm’s capital reserves and how it will fare if there's another financial crisis.

Wednesday saw the release of the second round results, which take into account a bank’s capital plan. Deutsche Bank Trust, Santander Holdings USA and Morgan Stanley were flagged.

Also on Friday, New York-based investment firm Gabelli Dividend & Income Trust’s $100 million of 5.25% series G cumulative preferreds – a deal priced Tuesday – moved to about $25.20 in trading, a trader said.

Morgan Stanley and Wells Fargo Securities LLC were the joint bookrunners. G. research LLC was the co-manager.

Proceeds will be used to purchase portfolio securities in accordance with the fund’s investment objective and policies.

In other news, investors continued to watch National General Holdings Corp. after the New York-based insurance company sold $175 million of series C noncumulative preferreds at par to yield 7.5%, following price talk at 7.625%.

A trader quoted the new issue at about $25.10 on Friday morning.

Morgan Stanley, UBS Securities LLC and Keefe Bruyette & Woods Inc. ran the books for the deal, the proceeds of which will be used for general corporate purposes.

On Friday morning, the company’s 7.5% series B noncumulative preferreds (Nasdaq: NGHCO) were trading at $25.51, up 5 cents. The stock closed at $25.63. The 7.625% $25-par subordinated notes due 2055 (Nasdaq: NGHCZ) were seen at $25.35, also up a nickel, before finishing the session at $25.41.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.